Direct association of socio-economic status with T-cell acute lymphoblastic leukaemia in children

Leukemia Research

Volumn 27, Issue 9, 2003, Pages 789-794

  Paes, Cybele A ^a   Viana, Marcos B ^a   Freire, Ricardo V ^b   Martins Filho, Olindo A ^c   Taboada, Diana C ^c   Rocha, Vanderson G ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Hemominas Foundation   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Acute lymphoblastic leukaemia; Immunophenotyping; Nutrition; Socio economic status

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CHILD NUTRITION; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; IMMUNOPHENOTYPING; INFANT; MAJOR CLINICAL STUDY; MORBIDITY; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; SOCIAL STATUS; SOCIOECONOMICS; STATISTICAL ANALYSIS; T CELL LEUKEMIA;

EID: 0038541873     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(03)00010-9     Document Type: Article

References (37)

1. Eden O.B., Harrison G., Richards S.et al. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997 (Medical Research Council Childhood Leukaemia Working Party). Leukaemia. 14:2000;2307-2320.
2. Maloney K.W., Shuster J.J., Murphy S.et al. Long-term results of treatment studies for childhood acute lymphoblastic leukaemia: Paediatric Oncology Group studies from 1986-1994. Leukaemia. 14:2000;2276-2285.
3. Chan L.C., Pegram S.M., Greaves M.F. Contribution of immunophenotype to the classification and differential diagnosis of acute leukaemia. Lancet. 1:1985;475-479.
4. Bene M.C., Bernier M., Castoldi G.et al. Impact of immunophenotyping on management of acute leukaemias. Haematologica. 84:1999;1024-1034.
5. Greaves M.F., Colman S.M., Beard M.E.J.et al. Geographical distribution of acute lymphoblastic leukaemia subtypes: second report of the Collaborative Group Study. Leukaemia. 7:1993;27-34.
6. Kamel A.M., Ghaleb F.M., Assem M.M.et al. Phenotypic analysis of T-cell acute lymphoblastic leukaemia in Egypt. Leuk. Res. 14:1990;601-609.
7. McKinney P.A., Alexander F.E., Cartwright R.A.et al. Acute lymphoblastic leukaemia in the UK by immunophenotype. Leukaemia. 7:1993;1630-1634.
8. Fleming A.F. Leukaemias in Africa. Leukaemia. 7(Suppl 2):1993;S138-S141.
9. Rajalekshmy K.R., Abitha A.R., Pramila R.et al. Immunophenotyping of acute lymphoblastic leukaemia in Madras, India. Leuk. Res. 18:1994;183-190.
10. Berkowicz M., Toren A., Rosner E.et al. Lymphomatous T-cell leukaemia in two Arab children. Is there a role for an environmental effect? Leukaemia. 8:1994;1995-1998.
11. Cabrera M.E.C., Labra S.G., Ugarte S.U.et al. Inmunofenotipo. Características clínicas y laboratório de la leucemia linfoblástica aguda en Chile. Rev. Med. Chil. 124:1996;293-299.
12. Miller D.R., Miller L.P. Acute lymphoblastic leukaemia in children: an update of clinical, biological, and therapeutic aspects. Crit. Rev. Oncol. Hematol. 10:1990;131-164.
13. Rego E.M., Garcia A.G., Viana S.R.et al. Characterization of acute lymphoblastic leukaemia subtypes in Brazilian patients. Leuk. Res. 20:1996;349-355.
14. Viana M.B., Murao M., Ramos G.et al. Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis. Arch. Dis. Child. 71:1994;304-310.
15. Viana MB, Fernandes RAF, Carvalho RI, et al. Low socio-economic status is a strong independent predictor of relapse in childhood acute lymphoblastic leukaemia. Int J Cancer 1998;(Suppl 11):56-61.
16. Viana M.B., Fernandes R.A.F., Oliveira B.M.et al. Nutritional and socio-economic status in the prognosis of childhood acute lymphoblastic leukaemia. Haematologica. 86:2001;113-120.
17. Bene M.C., Castoldi G., Knapp W.et al. Proposals for the immunological classification of acute leukaemias (European Group for the Immunological Characterization of Leukaemias, EGIL). Leukaemia. 9:1995;1783-1786.
18. Hamil P.V.V., Drizd T.A., Johnson C.L.et al. Physical growth: National Center for Health Statistics percentiles. Am. J. Clin. Nutr. 32:1979;607-629.
19. Dean AG, Dean JA, Coulombier D, et al. Epi Info, Version 6: a Word Processing, Database, and Statistics Program for Epidemiology on Microcomputers. Centers for Disease Control and Prevention, Atlanta, GA, USA; 1995.
20. Mora J.P. A new method for estimating a standardised prevalence of child malnutrition from anthropometric indicators. Bull. World Health Org. 67:1989;133-142.
21. Kamel A.M., Assem M.M., Jaffe E.S.et al. Immunological phenotypic pattern of acute lymphoblastic leukaemia in Egypt. Leuk. Res. 13:1989;519-525.
22. Greaves M.F., Pegram S.M., Chan L.C. Collaborative group study of the epidemiology of acute lymphoblastic leukaemia subtypes: background and first report. Leuk. Res. 9:1985;715-733.
23. Ramot B., Magrath I. Hypothesis: the environment is a major determinant of the immunological sub-type of lymphoma and acute lymohoblastic leukaemia in children. Br. J. Haematol. 52:1982;183-189.
24. Swensen A.R., Ross J.A., Severson R.K., Pollock B.H., Robison L.L. The age peak in childhood acute lymphoblastic leukaemia: exploring the potential relationship with socio-economic status. Cancer. 79:1997;2045-2051.
25. Ramot B., Ben-Bassat I., Many A.et al. Acute lymphoblastic leukaemia subtypes in Israel: the Sheba Medical Center experience. Leuk. Res. 6:1982;669-673.
26. Garand R., Bene M.C., Gardais J.et al. Incidence, clinical and laboratory features, and prognostic significance of immunophenotypic subgroups in acute lymphoblastic leukaemia: the GEIL experience. Recent Results Cancer Res. 131:1993;283-295.
27. Ludwig W.D., Raghavachar A., Thiel E. Immunophenotypic classification of acute lymphoblastic leukaemia. Baillieres Clin. Haematol. 7:1994;235-262.
28. Pui C.H., Rivera G.K., Hancock M.L.et al. Clinical significance of CD10 expression in childhood acute lymphoblastic leukaemia. Leukaemia. 7:1993;35-40.
29. Pui C.H., Boyett J.M., Relling M.V.et al. Sex differences in prognosis for children with acute lymphoblastic leukaemia. J. Clin. Oncol. 17:1999;818-824.
30. Pullen J., Shuster J.J., Link M.et al. Significance of commonly used prognostic factors differs for children with T cell acute lymphoblastic leukaemia (ALL), as compared to those with B-precursor ALL. A Paediatric Oncology Group (POG) study. Leukaemia. 13:1999;1696-1707.
31. -) acute lymphoblastic leukaemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. Leuk. Lymphoma. 28:1998;329-342.
32. Miller D.R., Miller L.P. Acute lymphoblastic leukaemia in children: an update of clinical, biological, and therapeutic aspects. Crit. Rev. Oncol. Hematol. 10:1990;131-164.
33. Aur R.J.A., Hanna M., Sabbah R.et al. Effective prevention of central nervous system leukaemia with intratecal methrotrexate, cytosine arabinoside, and hydrocortisone in childhood acute lymphocytic leukaemia. Haematol. Blood Transfus. 33:1990;504-510.
34. Hann I.M., Richards S.M., Eden O.B.et al. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Leukaemia. 12:1998;1249-1255.
35. Greaves M.F., Janossy G., Peto J.et al. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis. Br. J. Haematol. 48:1981;179-197.
36. Pui C.H., Behm F.G., Singh B.et al. Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukaemia. Blood. 75:1990;174-179.
37. Uckun F.M., Sensel M.G., Sun L.et al. Biology and treatment of childhood T-lineage acute lymphoblastic leukaemia. Blood. 91:1998;735-746.